(Total Views: 305)
Posted On: 08/19/2020 6:47:27 PM
Post# of 36541
One reason could be the title of the PR was not eye catching..."Generex Biotechnology Updates Agenda for Shareholder Conference Call
on Wednesday August 26th, 2020 at 9:30 AM"
Yesterday's title was much better "Generex Signs a Memorandum of Understanding with
Bintai Kinden to Advance the Clinical
Development & Commercialization of
Ii-Key-SARS-CoV-2 Coronavirus Vaccine for Malaysia"
Perhaps better title for today's PR would have been "Letter of Intent (LOI) signed with potential partners in China to develop the IiKey-SARS-CoV-2 vaccine for China with a proposed $5 million upfront
payment upon contract signing and minimum of $400 million if the vaccine is
proven successful in clinical trials"
and because of the eye catching title yesterday, there were many tweets/retweets of the PR, but there were not many tweets about GNBT's PR today.
on Wednesday August 26th, 2020 at 9:30 AM"
Yesterday's title was much better "Generex Signs a Memorandum of Understanding with
Bintai Kinden to Advance the Clinical
Development & Commercialization of
Ii-Key-SARS-CoV-2 Coronavirus Vaccine for Malaysia"
Perhaps better title for today's PR would have been "Letter of Intent (LOI) signed with potential partners in China to develop the IiKey-SARS-CoV-2 vaccine for China with a proposed $5 million upfront
payment upon contract signing and minimum of $400 million if the vaccine is
proven successful in clinical trials"
and because of the eye catching title yesterday, there were many tweets/retweets of the PR, but there were not many tweets about GNBT's PR today.
(5)
(0)Scroll down for more posts ▼
